N@N

Market Maker Surveillance Report. SGMO, LPTN, OVAS, CNAT, AUPH, NTLA, Losing Stocks With Lowest Price Friction For Thursday, D

December 22, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 5321 companies with "abnormal" market making, 2190 companies with positive Friction Factors and 3988 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Sangamo BioSciences Inc. (NASDAQ:SGMO), Lpath Inc. (NASDAQ:LPTN), OvaScience Inc. (NASDAQ:OVAS), Conatus Pharmaceuticals (NASDAQ:CNAT), Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), Intellia Therapeutics Inc. (NASDAQ:NTLA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  SGMO    $-0.350   -0.11%    335,824      31.02%    555,713      51.34%    -219,889     -6,283  
  LPTN    $-0.670   -0.18%    36,712       26.15%    60,366       43.01%    -23,654      -353    
  OVAS    $-1.620   -0.55%    3,662,154    34.04%    3,677,442    34.19%    -15,288      -94     
  CNAT    $-0.550   -0.13%    749,903      35.11%    886,942      41.53%    -137,039     -2,492  
  AUPH    $-0.520   -0.19%    2,773,511    39.03%    3,068,712    43.18%    -295,201     -5,677  
  NTLA    $-1.650   -0.10%    64,644       29.40%    67,822       30.84%    -3,178       -19     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows SGMO with a dollar loss Thursday of $-0.35000 and a Friction Factor of -6,283 shares. That means that it only took 6,283 more shares of selling than buying to move SGMO lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Sangamo BioSciences Inc. (NASDAQ:SGMO) - Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. Its proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome modification and gene regulation. The ZFPs could also be linked to a cleavage domain of a restriction endonuclease to create zinc finger nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off. Its lead ZFP Therapeutic candidate includes SB-728-T, a ZFN-mediated autologous cell product for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I/II clinical trials. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B and MPS I, a lysosomal storage disorder (LSD); and proprietary preclinical programs in hemophilia A and other LSDs. It has collaborative partnerships with Biogen Inc. (Biogen) to research, develop, and commercialize the preclinical ZFP Therapeutic development program in hemoglobinopathies, including sickle cell disease and beta-thalassemia; and with Shire International GmbH to research, develop, and commercialize the preclinical ZFP Therapeutic development program in Huntington s disease. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California..

Lpath Inc. (NASDAQ:LPTN) - Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies to treat a range of human diseases in the United States. It develops Lpathomab, a humanized monoclonal antibody (mAb) against lysophosphatidic acid that has completed Phase 1a clinical trial for various chronic pain conditions, including diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy-induced neuropathic pain, and pain associated with lumbosacral radiculopathy. The company also develops iSONEP, a mAb against sphingosine-1-phosphate, which is in Phase II clinical trial for the treatment of wet age-related macular degeneration; and ASONEP, a systemic formulation of sonepcizumab and a mAb against the bioactive lipid sphingosine-1-phosphate (S1P), which is in Phase IIa clinical trial to treat kidney cancer, leukemia, prostate cancer, neuroblastoma, lung cancer, pancreatic cancer, and melanoma. Lpath, Inc. has a collaboration agreement with Pfizer Inc. to develop and commercialize iSONEP. Lpath, Inc. is based in San Diego, California..

OvaScience Inc. (NASDAQ:OVAS) - .

Conatus Pharmaceuticals (NASDAQ:CNAT) - .

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - .

Intellia Therapeutics Inc. (NASDAQ:NTLA) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---